Patents by Inventor Suzanne V. Smith

Suzanne V. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7108845
    Abstract: There is provided a method of synthesis of a radiolabelled platinum chemotherapeutic agent comprising the steps of: converting a metal halide to a radiolabelled platinum halide wherein the radiolabel is a radioisotope of Pt; and synthesizing the radiolabelled platinum chemotherapeutic agent from the radiolabelled platinum halide.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: September 19, 2006
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventor: Suzanne V. Smith
  • Patent number: 6869589
    Abstract: The present invention relates to cryptate compounds useful as chelating agents. In particular, the present invention relates to functionalized derivatives of certain cryptate compounds. These functionalized derivatives are suitable for use in radiolabelling and similar applications. The present invention also relates to a method for diagnosis or therapy of a disease utilizing functionalized derivatives of cryptase compounds.
    Type: Grant
    Filed: January 5, 2000
    Date of Patent: March 22, 2005
    Assignees: Australian Nuclear Science & Technology Organization, The Australian National University
    Inventors: Suzanne V. Smith, John M. Harrowfield, Nadine M. Di Bartolo, Alan McLeod Sargeson
  • Publication number: 20030103896
    Abstract: There is provided a method of synthesis of a radiolabelled platinum chemotherapeutic agent comprising the steps of: converting a metal halide to a radiolabelled platinum halide wherein the radiolabel is a radioisotope of Pt; and synthesising the radiolabelled platinum chemotherapeutic agent from the radiolabelled platinum halide.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 5, 2003
    Inventor: Suzanne V Smith
  • Patent number: 5807535
    Abstract: A physiologically acceptable, radiolabelled compound of general formula (I) consisting of a compound of the ##STR1## where k is an integer from 2 to 5l is an integer from 1 to 5X and Y are independently selected from phenyl, naphthyl, pyridine or quinoline radical, each having at position 2 one of --OH, --SH, --NH.sub.2 or --COOH and each of X and Y can be optionally substituted by one or more amino, halogen, hydroxy, mercapto, nitro, cyano, thiocyano, alkyl, alkoxy, halogenoalkyl, acyl, acylamino, acyloxy, carboxyl, alkoxycarbonyl, carbamoyl, pyridoylamino, N-carboxyalkyl-carbamoyl, sulpho, sulphamoyl, mono- or dialkylated or phenylated sulphamoyl which can also carry one or more substituents R', alkylsulphonyl, alkoxysulphonyl, or by an optionally hydroxy-containing phenylsulphonyl or phenoxysulphonyl; where R' is as defined for X and Y; or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 15, 1995
    Date of Patent: September 15, 1998
    Assignee: Australian Nuclear Science & Technology Organisation
    Inventors: Suzanne V. Smith, Richard M. Lambrecht, Peter F. Schmidt, Fook-Thean Lee, Therese M. Donlevy, Nadine M. Di Bartolo
  • Patent number: 5550160
    Abstract: A physiologically acceptable, radiolabelled compound of general formula ##STR1## where k is an integer from 2 to 5l is an integer from 1 to 5X and Y are independently selected from phenyl or naphthyl radical each of which can be substituted by one or more amino, mono- or di- substituted amino, halogen, hydroxy, mercapto, nitro, cyano, thiocyano, alkyl, alkoxy, halogenoalkyl, acyl, acylamino, acyloxy, carboxyl, alkoxycarbonyl, carbamoyl, pyridoylamino, N-carboxyalkyl-carbamoyl, sulpho, sulphamoyl, mono- or dialkylated or phenylated sulphamoyl which can also carry one or more substituents R', alkylsulphonyl, alkoxysulphonyl, --(CH.sub.2).sub.p NHCOR", --COR" or by an optionally hydroxy-containing phenylsulphonyl or phenoxysulphonyl; or X and Y are independently selected from pyridine or quinoline radical each of which can be substituted by amine, halogen, hydroxy, alkyl, or carbamoyl; where R' is as defined for X and Y; R" is alkyl-L where L is halogen or other leaving group; 2,5-diketo-pyrrolinyl, --Het--CH.
    Type: Grant
    Filed: July 29, 1993
    Date of Patent: August 27, 1996
    Assignee: Australian Nuclear Science & Technology Organization
    Inventors: Suzanne V. Smith, Richard M. Lambrecht, Peter F. Schmidt, Fook-Thean Lee